A master cancer gene hijacks a ‘molecular crowbar’ to make breast cancer cells invasive January 22, 2021
The price of a drug should be based on its therapeutic benefits – not just what the market will bear January 19, 2021
A master cancer gene hijacks a ‘molecular crowbar’ to make breast cancer cells invasive January 22, 2021
The price of a drug should be based on its therapeutic benefits – not just what the market will bear January 19, 2021
Genetics Trastuzumab deruxtecan shows early promise in patients with non-breast/gastric cancers March 30, 2020 A HER2-targeted antibody-drug conjugate, fam-trastuzumab deruxtecan-nxki, showed signs of clinical activity in multiple non-breast/non-gastric cancer…